查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942761

2026年全球药物输注系统市场报告

Drug Infusion Systems Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，输液系统市场成长显着，预计到2025年将达到142.3亿美元，到2026年将达到155.1亿美元，复合年增长率为9.0%。过去几年的成长归因于住院率上升、慢性病盛行率上升、肿瘤和化疗的扩展、静脉给药使用量的增加以及输液技术的日益普及。

预计未来几年，药物输注系统市场将维持强劲成长，2030年市场规模将达到222.3亿美元，复合年增长率（CAGR）为9.4%。预测期内的成长主要归功于互联输注系统的日益普及、门诊和居家医疗对输註解决方案需求的不断增长、精准给药方式的推广、医院对工作流程自动化的日益重视以及对智能医疗基础设施投资的增加。预测期内的关键趋势包括智慧输注帮浦的日益普及、系统整合度的提高以减少给药误差、多通道输注设备的广泛应用、家庭输注治疗的增长以及对患者安全功能的日益重视。

预计未来医疗保健支出的成长将推动输液系统市场的发展。医疗保健支出是指在特定时期（通常为一年）内用于医疗产品和服务的总金额。随着医疗保健支出的增加，医院、诊所和其他医疗机构可以增加对先进输液系统的投资，从而增加对这些设备的需求。例如，根据英国国家统计局 (ONS) 2024 年 5 月发布的报告，2022 年至 2023 年，医疗保健总支出名目成长率为 5.6%，远高于 2022 年 0.9% 的成长率。因此，医疗保健支出的成长很可能推动输液系统市场的成长。

输液系统市场的主要企业正致力于开发先进技术，例如基于云端的输液管理系统，以改善患者照护、提高准确性并简化输液治疗的管理。基于云端的输液管理系统是能够透过云端监测、管理和追踪药物输注的数位化平台。例如，2023年6月，总部位于美国的全球领先先进输液治疗和药物输送解决方案提供商Eitan Medical推出了Eitan Insights，这是一款全新的基于云端的输液管理系统，旨在满足家庭和特殊输液的特定需求。 Eitan Insights为医疗专业人员提供即时数据和分析，从而实现远端病患监测并根据需要调整治疗方案。该系统透过最大限度地降低给药错误风险和提高处方通讯协定的依从性来增强用药安全性。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球输液系统市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施和互联生态系统
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 生物技术、基因组学和精准医学
  • 主要趋势
    • 智慧型输液帮浦的广泛应用
    • 剂量误差减少系统整合进展
    • 多通道输液装置的应用日益广泛
    • 扩大家庭输液治疗
    • 更加重视病患安全功能

第五章 终端用户产业市场分析

  • 医院
  • 门诊手术中心
  • 诊断中心
  • 居家医疗保健服务提供者
  • 专科诊所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球输液系统市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球输液系统市场规模、对比及成长率分析
  • 全球输液系统市场表现：规模与成长，2020-2025年
  • 全球输液系统市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 依产品类型
  • 弹性体输液系统、一次性输液系统、注射器输液系统、蠕动帮浦、多通道帮浦、病人自控式止痛（PCA）帮浦、胰岛素帮浦、植入式输液系统
  • 透过行政途径
  • 静脉注射、皮下注射、动脉注射、硬脊膜外注射及其他给药途径
  • 透过使用
  • 肿瘤学和化疗、糖尿病、疼痛缓解、营养、血液学、小儿科及其他用途
  • 最终用户
  • 医院、门诊手术中心、诊断中心和其他最终用户
  • 依类型细分：弹性体注塑系统
  • 无排气弹性体泵，排气弹性体泵
  • 按类型细分：一次性输液系统
  • 一次性输液泵，含一次性零件的静脉输液器
  • 按类型细分：注射器注射系统
  • 手动注射泵，电动注射泵
  • 按类型细分：蠕动泵
  • 单通道蠕动泵，多通道蠕动泵
  • 按类型细分：多通道泵
  • 通用型多通道输液泵，用于特定治疗的多通道输液泵
  • 按类型细分：患者自控镇痛（PCA）泵
  • 电子式PCA泵，机械式PCA泵
  • 按类型细分：胰岛素泵
  • 持续皮下胰岛素输注（CSII）帮浦、贴片式胰岛素帮浦
  • 按类型细分：植入式输液系统
  • 用于治疗慢性疼痛的植入式泵，用于化疗的植入式泵

第十章 区域与国家分析

  • 全球输液系统市场：区域分析、预测与趋势，2020-2025年、2025-2030年预测、2035年预测
  • 全球输液系统市场：依国家、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 药物输注系统市场：竞争格局及市场占有率（2024年）
  • 药物输注系统市场：公司估值矩阵
  • 药物输注系统市场：公司概况
    • Medtronic plc
    • Baxter International Inc.
    • B. Braun Melsungen AG
    • Becton, Dickinson and Company
    • Smiths Group plc

第37章：其他领先和创新企业

  • Terumo Corporation, Fresenius SE & Co. KGaA, ICU Medical Inc., Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed Holding AG, Abbott Diabetes Care Inc., Flowonix Medical Inc., Zyno Medical Inc., IRadimed Corporation, Debiotech SA, Valeritas Inc., Disetronic Medical Systems AG, Alaris Health Systems Inc., Hospira Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年药物输注系统市场：提供新机会的国家
  • 2030年药物输注系统市场：新兴细分市场机会
  • 2030年药物输注系统市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MDISN01_G26Q1

Drug infusion systems, classified as medical devices, are instrumental in delivering medications and fluids into a patient's body through a catheter or needle. This method of administration is commonly employed in hospitals, clinics, and various healthcare settings to dispense medications such as pain relievers, antibiotics, chemotherapy drugs, and fluids to patients.

The primary categories of drug infusion systems encompass elastomeric infusion systems, disposable infusion systems, syringe infusion systems, peristaltic pumps, multi-channel pumps, patient-controlled analgesia (PCA) pumps, insulin pumps, and implantable infusion systems. Elastomeric infusion systems, for instance, are flexible containers designed to provide a consistent rate of medication delivery for short-term infusion therapy. They find application in hospitals, clinics, and home care settings for short-term drug infusion therapy. These systems are versatile, administered through various modes such as intravenous, subcutaneous, arterially, epidurally, and others. They cater to diverse medical applications, including oncology and chemotherapy, diabetes, analgesia, nutrition, hematology, pediatrics, and more. Various end-users, such as hospitals, ambulatory surgical centers, diagnostic centers, and others, utilize elastomeric infusion systems for their respective needs.

Tariffs are impacting the drug infusion systems market by increasing costs of imported electronic components, sensors, precision pumps, and medical-grade plastics used in infusion devices. Hospitals and healthcare providers in North America and Europe are most affected due to reliance on imported components, while Asia-Pacific faces pricing pressure on device manufacturing and exports. These tariffs are contributing to higher device procurement costs and delayed equipment upgrades. However, they are also encouraging localized manufacturing, regional supplier diversification, and increased investments in domestic medical device production capabilities.

The drug infusion systems market research report is one of a series of new reports from The Business Research Company that provides drug infusion systems market statistics, including drug infusion systems industry global market size, regional shares, competitors with a drug infusion systems market share, detailed drug infusion systems market segments, market trends and opportunities, and any further data you may need to thrive in the drug infusion systems industry. This drug infusion systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug infusion systems market size has grown strongly in recent years. It will grow from $14.23 billion in 2025 to $15.51 billion in 2026 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increasing hospitalization rates, rising prevalence of chronic diseases, expansion of oncology and chemotherapy treatments, growing use of intravenous drug delivery, improved availability of infusion technologies.

The drug infusion systems market size is expected to see strong growth in the next few years. It will grow to $22.23 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing adoption of connected infusion systems, rising demand for ambulatory and homecare infusion solutions, expansion of precision drug delivery approaches, growing focus on workflow automation in hospitals, increasing investments in smart healthcare infrastructure. Major trends in the forecast period include increasing adoption of smart infusion pumps, rising integration of dose error reduction systems, growing use of multi-channel infusion devices, expansion of home-based infusion therapies, enhanced focus on patient safety features.

The rise in healthcare expenditure is expected to drive the growth of the drug infusion systems market in the future. Healthcare expenditure refers to the total amount allocated for healthcare goods and services within a specific timeframe, usually a year. As healthcare spending increases, hospitals, clinics, and other healthcare institutions gain more resources to invest in advanced drug infusion systems, resulting in higher demand for these devices. For example, in May 2024, reports from the Office for National Statistics (ONS), a UK-based national statistical institute, indicated that total healthcare spending increased by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of only 0.9% in 2022. Therefore, the increase in healthcare expenditure is likely to propel the growth of the drug infusion systems market.

Leading companies in the drug infusion systems market are focusing on developing advanced technologies, such as cloud-based infusion management systems, to improve patient care, enhance accuracy, and streamline the management of infusion therapies. Cloud-based infusion management systems are digital platforms that enable the monitoring, administration, and tracking of medication infusions via the cloud. For example, in June 2023, Eitan Medical, a U.S.-based global leader in advanced infusion therapy and drug delivery solutions, launched Eitan Insights, a new cloud-based infusion management system tailored to meet the specific needs of home and specialty infusions. Eitan Insights provides healthcare professionals with real-time data and analytics, allowing them to monitor patients remotely and adjust treatment plans as necessary. This system enhances medication safety by minimizing the risk of errors and improving adherence to prescribed protocols.

In November 2025, Biogen Inc., a US-based biotechnology company, acquired Alcyone Therapeutics for an undisclosed amount. Through this acquisition, Biogen aims to enhance its drug-delivery capabilities by integrating Alcyone's ThecaFlex DRx implantable intrathecal system, improving patient experience and expanding access to its CNS therapies. Alcyone Therapeutics Inc., a US-based company, specializes in drug infusion systems.

Major companies operating in the drug infusion systems market are Medtronic plc, Baxter International Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Smiths Group plc, Terumo Corporation, Fresenius SE & Co. KGaA, ICU Medical Inc., Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed Holding AG, Abbott Diabetes Care Inc., Flowonix Medical Inc., Zyno Medical Inc., IRadimed Corporation, Debiotech S.A., Valeritas Inc., Disetronic Medical Systems AG, Alaris Health Systems Inc., Hospira Inc., Mindray Medical International Limited

North America was the largest region in the drug infusion systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug infusion systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug infusion systems market consists of sales of smart pumps, syringe pumps, enteral infusion systems, and topical infusion systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Infusion Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses drug infusion systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug infusion systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug infusion systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Elastomeric Infusion System; Disposable Infusion System; Syringe Infusion System; Peristaltic Pump; Multi-Channel Pump; Patient-Controlled Analgesia (PCA) Pump; Insulin Pump; Implantable Infusion System
  • 2) By Route Of Administration: Intravenous; Subcutaneous; Arterial; Epidural; Other Routes Of Administration
  • 3) By Application: Oncology And Chemotherapy; Diabetes; Analgesia; Nutrition; Hematology; Pediatrics; Other Applications
  • 4) By End User: Hospitals; Ambulatory Surgical Centers; Diagnostic Centers; Other End Users
  • Subsegments:
  • 1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps; Vented Elastomeric Pumps
  • 2) By Disposable Infusion System: Disposable Infusion Pumps; IV Sets With Disposable Components
  • 3) By Syringe Infusion System: Manual Syringe Infusion Pumps; Electric Syringe Infusion Pumps
  • 4) By Peristaltic Pump: Single-Channel Peristaltic Pumps; Multi-Channel Peristaltic Pumps
  • 5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use; Multi-Channel Pumps For Specific Therapies
  • 6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps; Mechanical PCA Pumps
  • 7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps; Patch Insulin Pumps
  • 8) By Implantable Infusion System: Implantable Pumps For Chronic Pain; Implantable Pumps For Chemotherapy
  • Companies Mentioned: Medtronic plc; Baxter International Inc.; B. Braun Melsungen AG; Becton Dickinson and Company; Smiths Group plc; Terumo Corporation; Fresenius SE & Co. KGaA; ICU Medical Inc.; Tandem Diabetes Care Inc.; Insulet Corporation; Ypsomed Holding AG; Abbott Diabetes Care Inc.; Flowonix Medical Inc.; Zyno Medical Inc.; IRadimed Corporation; Debiotech S.A.; Valeritas Inc.; Disetronic Medical Systems AG; Alaris Health Systems Inc.; Hospira Inc.; Mindray Medical International Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Drug Infusion Systems Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Drug Infusion Systems Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Drug Infusion Systems Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Drug Infusion Systems Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Biotechnology, Genomics & Precision Medicine
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Smart Infusion Pumps
    • 4.2.2 Rising Integration Of Dose Error Reduction Systems
    • 4.2.3 Growing Use Of Multi-Channel Infusion Devices
    • 4.2.4 Expansion Of Home-Based Infusion Therapies
    • 4.2.5 Enhanced Focus On Patient Safety Features

5. Drug Infusion Systems Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centers
  • 5.3 Diagnostic Centers
  • 5.4 Homecare Providers
  • 5.5 Specialty Clinics

6. Drug Infusion Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Drug Infusion Systems Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Drug Infusion Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Drug Infusion Systems Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Drug Infusion Systems Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Drug Infusion Systems Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Drug Infusion Systems Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Drug Infusion Systems Market Segmentation

  • 9.1. Global Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System
  • 9.2. Global Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration
  • 9.3. Global Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications
  • 9.4. Global Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users
  • 9.5. Global Drug Infusion Systems Market, Sub-Segmentation Of Elastomeric Infusion System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps
  • 9.6. Global Drug Infusion Systems Market, Sub-Segmentation Of Disposable Infusion System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Disposable Infusion Pumps, IV Sets With Disposable Components
  • 9.7. Global Drug Infusion Systems Market, Sub-Segmentation Of Syringe Infusion System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps
  • 9.8. Global Drug Infusion Systems Market, Sub-Segmentation Of Peristaltic Pump, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps
  • 9.9. Global Drug Infusion Systems Market, Sub-Segmentation Of Multi-Channel Pump, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies
  • 9.10. Global Drug Infusion Systems Market, Sub-Segmentation Of Patient-Controlled Analgesia (PCA) Pump, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Electronic PCA Pumps, Mechanical PCA Pumps
  • 9.11. Global Drug Infusion Systems Market, Sub-Segmentation Of Insulin Pump, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps
  • 9.12. Global Drug Infusion Systems Market, Sub-Segmentation Of Implantable Infusion System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy

10. Drug Infusion Systems Market Regional And Country Analysis

  • 10.1. Global Drug Infusion Systems Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Drug Infusion Systems Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Drug Infusion Systems Market

  • 11.1. Asia-Pacific Drug Infusion Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Drug Infusion Systems Market

  • 12.1. China Drug Infusion Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Drug Infusion Systems Market

  • 13.1. India Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Drug Infusion Systems Market

  • 14.1. Japan Drug Infusion Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Drug Infusion Systems Market

  • 15.1. Australia Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Drug Infusion Systems Market

  • 16.1. Indonesia Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Drug Infusion Systems Market

  • 17.1. South Korea Drug Infusion Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Drug Infusion Systems Market

  • 18.1. Taiwan Drug Infusion Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Drug Infusion Systems Market

  • 19.1. South East Asia Drug Infusion Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Drug Infusion Systems Market

  • 20.1. Western Europe Drug Infusion Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Drug Infusion Systems Market

  • 21.1. UK Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Drug Infusion Systems Market

  • 22.1. Germany Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Drug Infusion Systems Market

  • 23.1. France Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Drug Infusion Systems Market

  • 24.1. Italy Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Drug Infusion Systems Market

  • 25.1. Spain Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Drug Infusion Systems Market

  • 26.1. Eastern Europe Drug Infusion Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Drug Infusion Systems Market

  • 27.1. Russia Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Drug Infusion Systems Market

  • 28.1. North America Drug Infusion Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Drug Infusion Systems Market

  • 29.1. USA Drug Infusion Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Drug Infusion Systems Market

  • 30.1. Canada Drug Infusion Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Drug Infusion Systems Market

  • 31.1. South America Drug Infusion Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Drug Infusion Systems Market

  • 32.1. Brazil Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Drug Infusion Systems Market

  • 33.1. Middle East Drug Infusion Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Drug Infusion Systems Market

  • 34.1. Africa Drug Infusion Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Drug Infusion Systems Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Drug Infusion Systems Market Regulatory and Investment Landscape

36. Drug Infusion Systems Market Competitive Landscape And Company Profiles

  • 36.1. Drug Infusion Systems Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Drug Infusion Systems Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Drug Infusion Systems Market Company Profiles
    • 36.3.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Smiths Group plc Overview, Products and Services, Strategy and Financial Analysis

37. Drug Infusion Systems Market Other Major And Innovative Companies

  • Terumo Corporation, Fresenius SE & Co. KGaA, ICU Medical Inc., Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed Holding AG, Abbott Diabetes Care Inc., Flowonix Medical Inc., Zyno Medical Inc., IRadimed Corporation, Debiotech S.A., Valeritas Inc., Disetronic Medical Systems AG, Alaris Health Systems Inc., Hospira Inc.

38. Global Drug Infusion Systems Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Drug Infusion Systems Market

40. Drug Infusion Systems Market High Potential Countries, Segments and Strategies

  • 40.1 Drug Infusion Systems Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Drug Infusion Systems Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Drug Infusion Systems Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer